Comparative analysis of Ziprasidone and Risperidone in the treatment of schizoprenia
Li Jie
Abstract
Li Jie
Abstract
Objective:To explore the efficacy and safety of Ziprasidone in treatment of schizophrenia.Methods:64 patients with schizophrenia were randomly assigned to Ziprasidone group(n=34) and Resperdone group(n=34),treatment 8 weeks.Positive and negative syndromescale(PANSS)and treatment emergent side effect scale(TESS) were used to evaluate the efficacy and side effects respectively.Results:The response rate and marked response rate in patients of Ziprasidone group were 64.7% and 82.4% after 8 weeks,similar to Risperdone group.Both the total PANSS scores and factor scores decreased significantly after treatment in two groups(67.6% and 85.2%).However,there were no significant differences between two groups.Total incidenceof side effects in Ziprasidone group was significantly lower than that in Risperidone group.Conclusion:Ziprasidone has a better efficacy in treatment of schizophrenia,wich is as effective as Resperidone and has fewer side effects compared with Risperdone.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the efficacy and safety of Ziprasidone in treatment of schizophrenia.Methods:64 patients with schizophrenia were randomly assigned to Ziprasidone group(n=34) and Resperdone group(n=34),treatment 8 weeks.Positive and negative syndromescale(PANSS)and treatment emergent side effect scale(TESS) were used to evaluate the efficacy and side effects respectively.Results:The response rate and marked response rate in patients of Ziprasidone group were 64.7% and 82.4% after 8 weeks,similar to Risperdone group.Both the total PANSS scores and factor scores decreased significantly after treatment in two groups(67.6% and 85.2%).However,there were no significant differences between two groups.Total incidenceof side effects in Ziprasidone group was significantly lower than that in Risperidone group.Conclusion:Ziprasidone has a better efficacy in treatment of schizophrenia,wich is as effective as Resperidone and has fewer side effects compared with Risperdone.
Key concepts: Ziprasidone, Risperidone, Schizophrenia (object-oriented programming), Internal medicine, Side effect (computer science), Medicine, Negative symptom, Significant difference